Jun 27, 2019 | Patient Education, Position Papers, Website
A special task-force collaboration by AAHKS members Stefano A. Bini, MD, Craig J. Della Valle, MD, Mark I. Froimson, MD, Charles P. Hannon, MD and Brett R. Levine, MD has produced a comprehensive source of education to address the opioid epidemic in the United States....
Jun 27, 2019 | In the News, Position Papers
Time reported last week that grocery chain, Hy-Vee, has contracted with stem cell company, Regenexx, to provide stem cell treatments to employees who are experiencing knee pain. Hy-Vee is requiring that employees take the stem cell therapy route before they can seek...
May 16, 2019 | In the News, Patient Education, Position Papers
The New York Times reported this week on “rogue clinics” offering stem cell and platelet rich plasma (PRP) as treatment for osteoarthritis pain. The US Food and Drug Administration, the company Regenexx and a number of researchers were interviewed for the article,...
Jan 25, 2019 | Position Papers
The two new position statements on the use of biologics and the use of opioids to treat arthritis issued by AAHKS last week have been endorsed by The Hip Society and The Knee Society. The statements have also garnered attention on AAHKS social media channels: Twitter...
Jan 17, 2019 | Position Papers
The AAHKS Board of Directors approved two new position statements this week that provide opinions on the use of opioids to treat osteoarthritis prior to joint replacement surgery and the use of biologics to treat advanced hip and knee arthritis. The statement on...
Oct 26, 2018 | Position Papers
This week, the American Academy of Orthopaedic Surgeons (AAOS), The Hip Society and The Knee Society officially endorsed the AAHKS Outpatient Joint Replacement position statement. “This AAHKS position statement was developed as a true collaboration in...
